XAGEOTCSoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends December 31Also trades as XAGEW
Longevity Health Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.11+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $277.24K
- P/E (TTM)
- –
- Dividend yield
- –
Longevity Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics companies for comparison
Valuation
| Measure | Longevity Health | Industry median |
|---|---|---|
| Market Cap | $277.24K | $197.05M |
| Enterprise Value | $241.77K | $106.56M |
| PS Ratio | 0.16 | 3.93 |
Enterprise value
| Measure | Longevity Health | Industry median |
|---|---|---|
| EV / Sales | 0.14 | 2.69 |
Income (trailing twelve months)
| Measure | Longevity Health | Industry median |
|---|---|---|
| Revenue | $1.69M | $57.94M |
| Gross Profit | $994.84K | $90.47M |
| Operating Income | -$5.79M | -$21.44M |
| Pretax Income | -$6.79M | -$14.45M |
| Net Income | -$6.83M | -$22.46M |
| EBITDA | -$5.73M | -$16.91M |
| EPS (Diluted) | -$3.51 | -$0.83 |
Margins
| Measure | Longevity Health | Industry median |
|---|---|---|
| Gross Margin | 59.0% | 52.3% |
| Operating Margin | -343.6% | -44.5% |
| Pretax Margin | -402.7% | -13.0% |
| Profit Margin | -404.8% | -39.2% |
| EBITDA Margin | -340.0% | -31.3% |
Returns
| Measure | Longevity Health | Industry median |
|---|---|---|
| Return on Assets (ROA) | -286.0% | -41.0% |
Growth
| Measure | Longevity Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 60.3% | 6.01% |
Balance sheet
| Measure | Longevity Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $35.47K | $62.42M |
| Net Cash (Debt) | $35.47K | $15.68M |
| Net Cash Per Share | $0.01 | $0.65 |
| Equity (Book Value) | -$8.70M | $48.79M |
| Book Value Per Share | -$3.51 | $1.36 |
| Tangible Book Value | -$8.71M | $23.06M |
| Working Capital | -$8.88M | $75.77M |
Financial position
| Measure | Longevity Health | Industry median |
|---|---|---|
| Current Ratio | 0.07 | 3.30 |
| Quick Ratio | 0.01 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Longevity Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.45M | -$12.35M |
Efficiency
| Measure | Longevity Health | Industry median |
|---|---|---|
| Asset Turnover | 0.71 | 0.38 |
| Inventory Turnover | 0.78 | 2.67 |
| Revenue Per Employee | $168.66K | $398.96K |
| Profits Per Employee | -$682.80K | -$732.08K |
| Employee Count | 10 | 73 |
Dividends and yields
| Measure | Longevity Health | Industry median |
|---|---|---|
| Earnings Yield | -2462.9% | -21.2% |
| Buyback Yield | -99.7% | -0.58% |
| Shareholder Yield | -99.7% | 0.00% |
Shares
| Measure | Longevity Health | Industry median |
|---|---|---|
| Shares Outstanding | 2,475,320 | 59,128,900 |
| Shares Change (YoY) | 119.3% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Shares Held by Institutions | 0.68% | 59.4% |
Taxes
| Measure | Longevity Health | Industry median |
|---|---|---|
| Income Tax | $36.26K | $91.50K |
Scores
| Measure | Longevity Health | Industry median |
|---|---|---|
| Altman Z-Score | -131.54 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Longevity Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.